• Sign up
  • Login

Scheme Profile

Nippon India Pharma Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
7,125
Inception Date
05-06-2004
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 436.0868 (19-Feb-2024) / 277.7333 (19-May-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 422.62 ( 2.47) ( 0.59 %)
  • Benchmark
  • S&P BSE Healthcare TRI
  • Entry Load
  • NIL
  • Exit Load
  • 1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
  • Expense Ratio (%)
  • 2.01
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 49.62 times
  • Portfolio P/B
  • 8.06 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.16

Risk Factors

  • Jenson's Alpha
  • 1.60
  • Standard Deviation
  • 4.47
  • Beta
  • 0.95
  • Sharpe
  • 0.88
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.51

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • S&P BSE Healthcare TRI
  • 11.56
  • 7.17
  • 29.40
  • 56.43
  • 15.79
  • 20.41
  • 13.46
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 65,56,349
  • 14.91
  • Lupin Ltd
  • Equity
  • 37,03,676
  • 8.40
  • Cipla Ltd
  • Equity
  • 31,00,000
  • 6.51
  • Apollo Hospitals Enterprise Ltd
  • Equity
  • 6,48,795
  • 5.79
  • Dr Reddys Laboratories Ltd
  • Equity
  • 5,50,030
  • 4.75

Sector Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 3,15,66,333
  • 81.37
  • Healthcare
  • 1,04,86,290
  • 15.57
  • Retail
  • 30,76,603
  • 3.06

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 7.18 9.10 11.56 2.86 7,125.28
2023 39.74 31.12 38.35 18.10 6,470.40
2022 -9.62 -9.58 -11.31 2.80 4,563.40
2021 23.04 17.96 20.57 21.69 5,397.29
2020 65.84 65.84 62.19 15.60 4,383.33
2019 1.77 4.22 -3.06 13.79 2,416.99
2018 3.88 -2.00 -5.45 6.67 2,682.96
2017 7.39 4.69 0.53 28.06 1,947.97
2016 -10.45 -12.31 -12.63 1.78 1,499.76
2015 19.32 13.13 15.78 -5.05 1,568.10

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2024 8.76 9.70 10.84 1.91 7,125.28
Dec-2023 11.98 11.42 11.01 10.27 6,470.40
Sep-2023 11.96 11.39 11.65 0.96 5,687.80
Jun-2023 16.91 15.61 17.79 9.49 4,959.59

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close